Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
खबर का सारांश
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
विश्वसनीय प्रकाशकों की ताज़ा खबरें संक्षिप्त विवरण के साथ पढ़ें। पूरी जानकारी के लिए मूल स्रोत खोलें।